dromlakhani Initial biochemical evaluation after radiological diagnosis
STEP 1 — Gather Information
Confirm Paget’s disease on plain radiographs (or radionuclide bone scan if needed). Assess liver function tests (ALT, AST, bilirubin) to determine if serum total ALP will be interpretable.
STEP 2 — Rule In / Rule Out
If liver enzymes are normal, serum total ALP is appropriate; if liver disease is present or ALP may be confounded, rule out total ALP and proceed to a specific bone formation/resorption marker.
STEP 3 — Classify or Stratify
Classify patients into:
- Normal hepatic function → use serum total ALP.
- Impaired hepatic function or unreliable ALP → use a specific bone formation marker (e.g., P1NP, BSAP, osteocalcin) or bone resorption marker (e.g., NTx, CTx) as appropriate.
STEP 4 — Decide
Order the selected biochemical test(s) to establish baseline bone turnover before initiating treatment or monitoring disease activity.
Clinical Guardrails / Mimics / Pitfalls
Do not rely on total ALP in cholestasis, hepatitis, or infiltrative liver disease without confirming bone‑specific origin; avoid nonspecific markers like hydroxyproline; interpret changes using least significant change (LSC) for the chosen assay; ensure test availability and insurance coverage.
Concrete Clinical Example
A 70‑year‑old woman has an incidental lytic lesion in the right iliac wing on pelvic X‑ray; a bone scan confirms focal uptake. Liver enzymes are normal. Serum total alkaline phosphatase is ordered to establish baseline bone turnover.
Source: Paget’s Disease of Bone: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2014, DOI:10.1210/jc.2014-2910